These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19387008)

  • 1. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
    Grand FH; Hidalgo-Curtis CE; Ernst T; Zoi K; Zoi C; McGuire C; Kreil S; Jones A; Score J; Metzgeroth G; Oscier D; Hall A; Brandts C; Serve H; Reiter A; Chase AJ; Cross NC
    Blood; 2009 Jun; 113(24):6182-92. PubMed ID: 19387008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
    Makishima H; Cazzolli H; Szpurka H; Dunbar A; Tiu R; Huh J; Muramatsu H; O'Keefe C; Hsi E; Paquette RL; Kojima S; List AF; Sekeres MA; McDevitt MA; Maciejewski JP
    J Clin Oncol; 2009 Dec; 27(36):6109-16. PubMed ID: 19901108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function c-CBL mutations associated with uniparental disomy of 11q in myeloid neoplasms.
    Ogawa S; Sanada M; Shih LY; Suzuki T; Otsu M; Nakauchi H; Koeffler HP
    Cell Cycle; 2010 Mar; 9(6):1051-6. PubMed ID: 20237427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
    Sanada M; Suzuki T; Shih LY; Otsu M; Kato M; Yamazaki S; Tamura A; Honda H; Sakata-Yanagimoto M; Kumano K; Oda H; Yamagata T; Takita J; Gotoh N; Nakazaki K; Kawamata N; Onodera M; Nobuyoshi M; Hayashi Y; Harada H; Kurokawa M; Chiba S; Mori H; Ozawa K; Omine M; Hirai H; Nakauchi H; Koeffler HP; Ogawa S
    Nature; 2009 Aug; 460(7257):904-8. PubMed ID: 19620960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
    Dunbar AJ; Gondek LP; O'Keefe CL; Makishima H; Rataul MS; Szpurka H; Sekeres MA; Wang XF; McDevitt MA; Maciejewski JP
    Cancer Res; 2008 Dec; 68(24):10349-57. PubMed ID: 19074904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.
    Aranaz P; Hurtado C; Erquiaga I; Miguéliz I; Ormazábal C; Cristobal I; García-Delgado M; Novo FJ; Vizmanos JL
    Haematologica; 2012 Aug; 97(8):1234-41. PubMed ID: 22315494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.
    Javadi M; Richmond TD; Huang K; Barber DL
    J Biol Chem; 2013 Jul; 288(27):19459-70. PubMed ID: 23696637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
    Brecqueville M; Rey J; Bertucci F; Coppin E; Finetti P; Carbuccia N; Cervera N; Gelsi-Boyer V; Arnoulet C; Gisserot O; Verrot D; Slama B; Vey N; Mozziconacci MJ; Birnbaum D; Murati A
    Genes Chromosomes Cancer; 2012 Aug; 51(8):743-55. PubMed ID: 22489043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.
    Hanson HL; Wilson MJ; Short JP; Chioza BA; Crosby AH; Nash RM; Marks KJ; Mansour S
    Am J Med Genet A; 2014 Apr; 164A(4):1003-9. PubMed ID: 24458550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
    Olcaydu D; Rumi E; Harutyunyan A; Passamonti F; Pietra D; Pascutto C; Berg T; Jäger R; Hammond E; Cazzola M; Kralovics R
    Haematologica; 2011 Mar; 96(3):367-74. PubMed ID: 21173100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired uniparental disomy of chromosome 9p in hematologic malignancies.
    Wang L; Wheeler DA; Prchal JT
    Exp Hematol; 2016 Aug; 44(8):644-52. PubMed ID: 26646991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.
    Schnittger S; Bacher U; Alpermann T; Reiter A; Ulke M; Dicker F; Eder C; Kohlmann A; Grossmann V; Kowarsch A; Kern W; Haferlach C; Haferlach T
    Haematologica; 2012 Dec; 97(12):1890-4. PubMed ID: 22733026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
    Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational status of myeloproliferative neoplasms.
    Rumi E; Elena C; Passamonti F
    Crit Rev Eukaryot Gene Expr; 2010; 20(1):61-76. PubMed ID: 20528738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML).
    Shiba N; Hasegawa D; Park MJ; Murata C; Sato-Otsubo A; Ogawa C; Manabe A; Arakawa H; Ogawa S; Hayashi Y
    Blood; 2012 Mar; 119(11):2612-4. PubMed ID: 22138511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias.
    Fitzgibbon J; Smith LL; Raghavan M; Smith ML; Debernardi S; Skoulakis S; Lillington D; Lister TA; Young BD
    Cancer Res; 2005 Oct; 65(20):9152-4. PubMed ID: 16230371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
    Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
    Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
    [No Abstract]   [Full Text] [Related]  

  • 19. Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.
    Chase A; Leung W; Tapper W; Jones AV; Knoops L; Rasi C; Forsberg LA; Guglielmelli P; Zoi K; Hall V; Chiecchio L; Eder-Azanza L; Bryant C; Lannfelt L; Docherty L; White HE; Score J; Mackay DJ; Vannucchi AM; Dumanski JP; Cross NC
    Leukemia; 2015 Oct; 29(10):2069-74. PubMed ID: 26114957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous recombination of wild-type JAK2, a novel early step in the development of myeloproliferative neoplasm.
    Vilaine M; Olcaydu D; Harutyunyan A; Bergeman J; Tiab M; Ramée JF; Chen JM; Kralovics R; Hermouet S
    Blood; 2011 Dec; 118(24):6468-70. PubMed ID: 22161852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.